Website & contact details
- Website
Central Pharma Biotechnica Limited
- Incorporated
- 5 February 2021 (5 years)
- Industry
- Manufacture of fertilizers and nitrogen compounds (20150) Other service activities n.e.c. (96090)
- Directors
- Schalk Willem De Beer
- Accounts type
- Audit exemption subsidiary
- Region
- East of England
- Address
- Central Pharma Caxton RoadElm Farm Ind EstateBedfordMK41 0HT
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 24 March 2027
- Last conf. stmt
- 10 March 2026
Charges
- Total
- 1
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 0
Officers 2 active
Officer details are public data from the Companies House register.
De Beer, Schalk Willem
Director · Appointed 28 March 2022
South African
Born November 1961
Director · Appointed 5 February 2021
British
Born January 1961 (65)
Officer history (1 former)
31 December 2025
28 March 2022
Appointed De Beer, Schalk Willem as Director
5 February 2021
5 February 2021
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 5 February 2021
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 08126719
Group structure 5 companies
Ownership group derived from the Companies House PSC register
Central Pharma Biotechnica Limited This company Owns 75–100% of shares
Central Pharma Cell and Gene Therapy Ltd Owns 75–100% of shares
Central Pharma Contract Packing Limited Owns 75–100% of shares
Central Pharma Manufacturing Ltd Owns 75–100% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Cash
- £48,796
- Turnover
- £562,944
- Profit Before Tax
- (£307,314)
- Employees
- 3
- Current Ratio
- 0.2x
- Profit Margin
- -55%
Trend
Shareholder Funds
Balance sheet detail
| 2024 | 2023 | 2021 | |
|---|---|---|---|
| Fixed Assets | £18,586 | £23,318 | £41,569 |
| Current Assets | £260,133 | £471,654 | £431,178 |
| Debtors | £72,731 | £106,275 | £253,687 |
| Cash | £48,796 | £104,825 | |
| Creditors (< 1 year) | £1,588,413 | £1,497,352 | £368,607 |
| Net Current Assets | (£1,328,280) | (£1,025,698) | £62,571 |
| Net Assets | (£1,002,380) | £101,648 | |
| Shareholder Funds | (£1,309,694) | (£1,002,380) | £101,648 |
| Turnover | £562,944 | ||
| Cost of Sales | £453,700 | ||
| Gross Profit | £109,244 | ||
| Admin Expenses | £416,558 | ||
| Profit Before Tax | (£307,314) | ||
| Tax | £0 | ||
| Profit for Period | (£307,314) | ||
What Central Pharma Biotechnica say about themselves
“Biotechnica offer a large range of agricultural biostimulants and biofertilizers. We are the UK's largest manufacturer of seaweed extract.”
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 5 November 2026 | Accounts filing | |||
| 5 November 2026 | Audit exemption subsidiary accounts | 31 December 2025 | ||
| 28 October 2026 | Resolutions | |||
| 27 October 2026 | Other filing | |||
| 27 October 2026 | Other filing |
Some other companies at this address
Other companies in this industry
Carlisle
Cardiff
London
London
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →